logo-large
  • Browse Categories

Publications by authors named "Junbum Im"

Claim this Profile
T
The proto-oncogenic miR-106a-363 cluster enhances adverse risk acute myeloid leukemia through mitochondrial activation.
Nadine Sperb, Irina A Maksakova, Leo Escano, Libin Abraham, Liam MacPhee, Dexter Kim, Junbum Im

Leukemia· May 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements.
Sarah Grasedieck, Ariene Cabantog, Liam MacPhee, Junbum Im, Christoph Ruess

Haematologica· August 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B.
Justin J King, Faezeh Borzooee, Junbum Im, Mahdi Asgharpour, Atefeh Ghorbani

ACS Pharmacol Transl Sci· August 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AID, APOBEC3A and APOBEC3B efficiently deaminate deoxycytidines neighboring DNA damage induced by oxidation or alkylation.
Cody P Diamond, Junbum Im, Erynn A Button, David N G Huebert, Justin J King

Biochim Biophys Acta Gen Subj· November 2019


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: